SCHEMBL6468065

SCHEMBL6468065

CCOc1cc(-n2cc(NC(N)=O)c(C(N)=O)n2)ccc1Br

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ITK Q08881 1/20 0.43
ALDH1A1 P00352 2/20 0.39
TSHR P16473 1/20 0.39
MAPK10 P53779 1/20 0.39
KDM4E B2RXH2 3/20 0.38
HTT P42858 2/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
NPC1 O15118 4/20 0.38
LMNA P02545 1/20 0.37
KMT2A Q03164 2/20 0.36
RAB9A P51151 1/20 0.36
MEN1 O00255 1/20 0.36
PKM P14618 1/20 0.36
NCOA1 Q15788 1/20 0.36
NCOA3 Q9Y6Q9 1/20 0.36
MAPT P10636 2/20 0.35
IRAK4 Q9NWZ3 1/20 0.35
PTK6 Q13882 1/20 0.35
PARP1 P09874 1/20 0.35
TP53 P04637 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6505988 0.84 NPC1 (0.40) ALDH1A1TSHRKDM4ESMN1; SMN2NPC1
SCHEMBL6499437 0.84 ITK (0.40) ITKALDH1A1TSHRMAPK10KDM4E
SCHEMBL6470268 0.84 ITK (0.42) ITKALDH1A1TSHRMAPK10KDM4E
SCHEMBL6507055 0.82 ITK (0.53) ITKALDH1A1TSHRMAPK10KDM4E
SCHEMBL6467585 0.81 SCN9A (0.44) ITKALDH1A1TSHRMAPK10KDM4E
SCHEMBL6500119 0.81 ITK (0.43) ITKALDH1A1KDM4EHTTSMN1; SMN2
SCHEMBL6500313 0.81 ITK (0.47) ITKALDH1A1KDM4EHTTSMN1; SMN2
SCHEMBL6510177 0.81 ITK (0.42) ITKALDH1A1TSHRMAPK10KMT2A
SCHEMBL6500256 0.80 ITK (0.40) ITKALDH1A1TSHRMAPK10KDM4E
SCHEMBL6466261 0.80 KIF11 (0.50) ITKKDM4EHTTSMN1; SMN2NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050197338-A1 Substituted pyrazole urea compounds for the treatment of inflammation PHARMACIA AND UPJOHN COMPANY LLC 2005-09-08 US disclosed
WO-2005037797-A1 SUBSTITUTED PYRAZOLE UREA COMPOUNDS FOR THE TREATMENT OF INFLAMMATION PHARMACIA CORPORATION (US) 2005-04-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050197338-A1 Substituted pyrazole urea compounds for the treatment of inflammation IL4, ARG2, CASP4 ITK 4236/4885ALDH1A1 846/4885TSHR 1759/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.